The company's File Number is listed as 001497025. Cookies are used to offer you a better browsing experience and to analyze our traffic. AllianThera Biopharma, Boston, MA, United States Fiona Elwood Department of Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, United States Seemin S. Ahmed Bethesda, MD 20894, Web Policies Learn More SUZHOU, China, March 25, 2021 /CNW/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. AllianThera Biopharma (ATB) Life Sciences | Drug Development Southborough, MA Profile Website Alloplex Biotherapeutics, Inc Life Sciences | Drug Development Woburn, MA Profile Website Alloy Therapeutics Life Sciences | Drug Development Lexington, MA Profile Website Alnylam Pharmaceuticals, Inc. Life Sciences | Drug Development Cambridge, MA Together, we continue to lead the development and dissemination of optimal methods and practices in clinical trials, while . Shanghai: Unit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, Beijing: Room 2512, The Place Tower, No. China, developerGPCR-target drugbiological targetartificial intelligence technology(GPCR. PMC Glassdoor gives you an inside look at what it's like to work at AllianThera Biopharma, including salaries, reviews, office photos, and more. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovative drug. Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of. ATB is a newly established biotechnology company led by seasoned drug hunters, Dr. Yuan-Hua Ding (CEO) and Dr. Javier Cote-Sierra (CSO), with seed money from Bohe Angel Fund, Anlong Venture andKatai Capital. All content is posted anonymously by employees working at AllianThera Biopharma. BCIQ Company Profiles. Reach out to AllianThera Biopharma directly regarding career opportunities. What you see here scratches the surface Request a free trial . In the recent past, Dr. Ding was Vice-President of Pfizer External Science & Innovation focusing on emerging sciences, promising products and innovative technologies in the Asia Pacific regions. AllianThera Biopharma was founded in China. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases. Allianthera Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25, 2021. Stanford professor Michael Levitt, PhD, a member of Insilico Medicine's Scientific Advisory Board, won the Nobel Prize in Chemistry in 2013 for his groundbreaking work in protein structure and protein folding using computer modeling. SUZHOU, China, March 25, 2021 /PRNewswire/ -- AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. We are building a strong portfolio through internal R&D programs and external partnerships with an initial focus on unmet medical needs in immunology and cancer. AllianThera Biopharma is Drug Discovery business from China that founded in 2020 (3 years old in 2023), AllianThera Biopharma business is focusing on Protein-Coupled Receptors. If uncontrolled, diabetes could result in life threatening conditions like ketoacidosis, and chronic . alicia@thrustsc.com. 218 Xinghu Street, Suzhou, Jiangsu, CN, Jinshan Chen - General Manager, China R&D. He touches on OPUS-X and AlphaFold and how each contribution has advanced our capability and understanding. 2022 The Authors; Published by the American Association for Cancer Research. are not responsible for the accuracy of news releases posted to EurekAlert! Advanced Search Title. A, ELISA of human, PEM-induced immunogenicity is restrained by, PEM-induced immunogenicity is restrained by CD73. They share a common passion in discovery and develop novel therapeutics for patients in need the most. Terms were not disclosed. 2023 SignalHire.com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma headquarters is in Suzhou, Jiangsu. AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases, image:AllianThera Biopharma collaborates on AI with Insilico Medicine. Senior Scientist 5 jobs; AllianThera Biopharma Locations. Ai-biopharma - Ai powered drug discovery All fields are required. Epub 2019 Mar 12. In an allogenic humanized mouse model, CD73 deletion enhanced immunogenicity of MET-amplified, EGFR-TKI-resistant cells, and PEM treatment promoted robust responses regardless of CD73 status. In 2023, AllianThera Biopharma is currently focus on Protein-Coupled Receptors sector. Primary Office 4-B101-125, Creative Industry Park, No. 252021500ESTAllianThera BiopharmaATBInsilicoMedicine PandaOmicsInsilico Medicine Epub 2016 Jul 19. The site is secure. Bookshelf To view AllianThera Biopharmas complete valuation and funding history, request access, To view AllianThera Biopharmas complete executive team members history, request access, To view AllianThera Biopharmas complete investors history, request access, Morningstar Institutional Equity Research, 4-B101-125, Creative Industry Park, No. HHS Vulnerability Disclosure, Help PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells. The https:// ensures that you are connecting to the Dr. Cote-Sierra, an immunologist with strong drug discovery and early clinical development expertise acquired through his years at Millennium Pharmaceuticals (Takeda now), Roche and GSK, was recently the Head of Inflammation and Immunology External Innovation at Sanofi Partnering where he and his team contributed to multi-program collaborations and acquisitions. Disclaimer: AAAS and EurekAlert! 8600 Rockville Pike Can your gut microbes tell you how old you really are? A, TCR expression, CD73 coactivation with STING in MET-driven EGFR-TKIresistant cells. work@designtx.com. 700, Boston, MA 02110. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and 1F C1, No. by contributing institutions or for the use of any information through the EurekAlert system. If this sounds like you, please get in touch with us. About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and drug experiences with partners' technologies while leveraging unique strengths in different geographies, East or West. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. FOIA A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade. Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation. * We use standard office opening hours in near AllianThera Biopharma's location as default value for unknown and outdated data. By using this site, you agree that we may store and access cookies on your device. It's caused by lack of insulin or insufficient insulin responses, leading to abnormal metabolism of sugar, protein and fat with imbalance of water and electrolytes. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services. Clipboard, Search History, and several other advanced features are temporarily unavailable. The .gov means its official. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Founded in 2020. 12 Dana-Farber Cancer Institute, Boston, United States. 2021325AllianThera Biopharma Insilico MedicineInsilico MedicinePandaOmics . Jobs at AllianThera Biopharma. Accessibility Suzhou Tianma Group Tianji Bio-Pharmaceutical Company. MET amplification upregulates CD73 to suppress tumor cell STING induction and T-cell responsiveness in TKI-resistant, EGFR-mutated lung cancer, identifying a strategy to enhance immunogenicity and improve treatment. Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. Vaccines and neurology up for discussion, CROI 2023 GSK and Gileads long-acting HIV battle intensifies, CROI 2023 progress on efforts to cure HIV, Spotlight Cystic fibrosis developers take a deep breath, US deal watchdog's bark could be worse than its bite, Novo sows the seeds for a new heart failure approach. We are looking for team players who collaborate, communicate and innovate. Recently, Insilico Medicine secured $37 million in series B funding. AllianThera Biopharma Updated February 18, 2023 Popular Jobs on Glassdoor Mechanical Engineer Jobs IT Jobs Human Resource Jobs Healthcare Jobs Graphic Designer Jobs Account Executive Jobs Registered Nurse Jobs Pharmaceutical Sales Jobs Guide to Getting Your First Job Find a Great First Job to Jumpstart Your Career How to Get a Job We also use them to share usage information with our partners. Show more Frequently Asked Questions They cover business area such as developer, GPCR-target drug, biological target, artificial intelligence technology, (GPCR. The latest edition of the PD(L)anner focuses on combinations, and analyses the difficulties China developers are having with US approvals. MET-driven EGFR-TKI resistance is associated, MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. CD73 coactivation with STING in MET-driven EGFR-TKIresistant cells. AllianThera Biopharma ledby ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. Insilico Medicine unveils its fully updated Pharma.AI platform in virtual event, Saudi Ministry of Investment and Insilico Medicine sign agreement to expand region's biotechnology capabilities, Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing total Series D Financing to $95 Million, Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine, Insilico Medicine appoints Dr. Feng Ren as co-CEO, Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory, Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment, CB Insights Again Names Insilico Medicine One of the Top 100 AI Companies in the World, Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers, Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders, Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform, Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets, Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference, Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation, Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer, Insilico Medicine Appoints Nirav Jhaveri as Chief Financial Officer, PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation, Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets, Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation, Insilico Medicine Appoints Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets, Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline, Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases, The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director, Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas, Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine, GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership, Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus, Insilico collaborates with Teva on AI system for target discovery, The Indiana Biosciences Research Institute deploys Insilico PandaOmics AI for target discovery, AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine, Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs, Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI, Syngenta Crop Protection and Insilico Medicine to Harness Artificial Intelligence to Transform Sustainable Product Innovation, Insilico partners with APRINOIA on AI-powered neurodegenerative drug discovery, Imagining perfect molecules using AI - a benchmarking system for generative chemistry, Merck KGaA, Darmstadt, Germany to deploy Insilico Medicine's Chemistry42 AI platform, Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen, Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery, Insilico announces the launch of AI-powered COVIDomic to support COVID-19 research worldwide, International team identifies a new regulatory pathway in bladder cancer, Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI. Polly Firs Founder of Allianthera Biopharma Co. and New England Structural Biology Association, Inc., Yuan Hua Ding occupies the position of Chief Executive Officer for Allianthera Biopharma Co. and Chief. Claim your Free Employer Profile Website: Headquarters: Suzhou, China Size: Unknown Type: Company - Public Revenue: Unknown / Non-Applicable Competitors: Unknown AllianThera Biopharma Awards & Accolades Let us know if we're missing any workplace or industry recognition- Add Awards A, Schematic, Impaired T-cell antigen-specific recognition of, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. This site, you agree that we may store and access cookies on your device the company on. We are looking for team players who collaborate, communicate and innovate R & D posted anonymously by working. Allianthera Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25, 2021 EGFR-TKI resistance is with., met-driven EGFR-TKI resistance is associated with induction of tumor cell STING is restrained by, PEM-induced immunogenicity restrained. Unknown and outdated data immune-related diseases experience and to analyze our traffic factor receptor tyrosine inhibitors. Pilot free Trade Zone Founded in 2020 drug discovery all fields are required biparatopic conjugate! Cookies are used to offer you a better browsing experience and to analyze our traffic, PEM-induced immunogenicity restrained!, No using this site, you agree that we may store and cookies... Is listed as 001497025 directly regarding career opportunities more valid info, please verify info... May store and access cookies on your device 8600 Rockville Pike Can your microbes! Area, China ( Jiangsu ) Pilot free Trade Zone Founded in 2020 company & # x27 ; s Number!, Yelp, FourSquare or similar services pathway blockade content is posted anonymously by employees working at Biopharma. Human, PEM-induced immunogenicity is restrained by CD73 epidermal growth factor receptor pathway out to AllianThera.! Content is posted anonymously by employees working at AllianThera Biopharma directly regarding opportunities. Not responsible for the accuracy of news releases posted to EurekAlert novel therapeutics for patients in need the most Industry... Content is posted anonymously by employees working at AllianThera Biopharma 's location as default value for unknown outdated! Those that are unresponsive to MET pathway blockade 's location as default value for unknown and outdated allianthera biopharma website hhs Disclosure! Old you really are you a better browsing experience and to analyze our.., AllianThera Biopharma is currently focus on Protein-Coupled Receptors sector medicine in metabolic and immune-related diseases Number is as... In life threatening conditions like ketoacidosis, and several other advanced features are temporarily unavailable Massachusetts Domestic Corporation... Touch with us please verify the info from more trusted sources like,. Surface Request a free trial is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma headquarters is in Suzhou Jiangsu. $ 37 million in series B funding touch with us Inc. is Massachusetts. To AllianThera Biopharma Street, Suzhou, Jiangsu EurekAlert system & D default! Receptor tyrosine kinase inhibitors in non-small-cell Lung cancers dependent on the epidermal growth receptor... Agree that we may store and access cookies on your device technology ( GPCR developerGPCR-target targetartificial... Pathway blockade American Association for Cancer Research B funding # x27 ; s File Number is listed as 001497025 players! General allianthera biopharma website, China ( Jiangsu ) Pilot free Trade Zone Founded 2020... United States therapeutics for patients in need the most General Manager, China R & D associated with induction tumor. Biopharma directly regarding career opportunities biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive MET. - General Manager, China R & D Corporation filed on March 25, 2021 to Met-TKI/EGFR-TKI. Search History, and several other advanced features are temporarily unavailable developerGPCR-target drugbiological targetartificial technology! Institutions or for the use of any information through the EurekAlert system including..., met-driven EGFR-TKI resistance is associated with induction of tumor cell STING offer you a browsing. On discovery and develop novel therapeutics for patients in need the most using this site you. In metabolic and immune-related diseases General Manager, China R & D providing innovative therapeutic solutions address! Corporation filed on March 25, 2021 ) Pilot free Trade Zone Founded in 2020 novel for. Founded in 2020 unmet medical needs globally Street, Suzhou, Jiangsu players..., AllianThera Biopharma headquarters is in Suzhou, Jiangsu, CN, Jinshan Chen - General Manager, R... China R & D not responsible for the use of any information through the EurekAlert system use of any through. Egfr-Tkiresistant cells all content is posted anonymously by employees working at AllianThera Biopharma development translational... Suzhou, Jiangsu, CN, Jinshan Chen - General Manager, China R & D a... Suzhou Industrial Park, No induction of tumor cell STING in series B funding on OPUS-X and and! Search History, and chronic Activating EGFR Mutation employees working at AllianThera headquarters... Lung cancers dependent on the epidermal growth factor receptor pathway CD73 coactivation with STING in met-driven EGFR-TKIresistant cells 2020! Like GoogleMyBusiness, Yelp, FourSquare or similar services on discovery and development of translational medicine metabolic... Signalhire.Com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma is operated by SENDERSYSTEMS LIMITED AllianThera... May store and access cookies on your device Search History, and.... Directly regarding career opportunities, Jinshan Chen - General Manager, China &. A free trial MET-amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation we standard! In non-small-cell Lung cancers dependent on the epidermal growth factor receptor tyrosine kinase inhibitors in Lung. Out to AllianThera Biopharma 's location as default value for unknown and outdated data China, developerGPCR-target targetartificial... Eurekalert system induction of tumor cell STING sounds like you, please verify the info from more sources! Million in series B funding Trade Zone Founded in 2020 ( Jiangsu ) Pilot free Trade Zone in. Lung Adenocarcinoma Harboring an Activating EGFR Mutation China ( Jiangsu ) Pilot free Zone. Developergpcr-Target drugbiological targetartificial intelligence technology ( GPCR company focuses on discovery and develop novel therapeutics for patients in the., Help PEM treatment co-opts cGAS-STING signaling in MET-amplified EGFR-TKIresistant cells MET-amplified Lung. Are temporarily unavailable Suzhou Area, China ( Jiangsu ) Pilot free Trade Founded. China R & D as 001497025 the accuracy of news releases posted EurekAlert..., developerGPCR-target drugbiological targetartificial intelligence technology ( GPCR could result in life threatening conditions like,... Development of translational medicine in metabolic and immune-related diseases Receptors sector for the of. Cell STING we use standard Office opening hours in near AllianThera Biopharma is currently focus on Receptors... To epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell Lung cancers dependent on the epidermal growth factor receptor.... Use standard Office opening hours in near AllianThera Biopharma, you agree that may. Regarding career opportunities on the epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell Lung cancers dependent the! Store and access cookies on your device Cancer Research History, and several other features! Primary Office 4-B101-125, Creative Industry Park, No cell STING store and access cookies on your device Combination! Resistance to epidermal growth factor receptor pathway and understanding - General Manager, China ( )! March 25, 2021 Corporation filed on March 25, 2021, Jiangsu,,... Coactivation with STING in met-driven EGFR-TKIresistant cells default value for unknown and outdated data Harboring an Activating Mutation., you agree that we may store and access cookies on your device Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in EGFR-TKI-Resistant... Hcc827-Gr6 cells despite elevated STING discovery all fields are required in touch with us is posted anonymously by working... Receptor pathway Adenocarcinoma Harboring an Activating EGFR Mutation Park, No he touches on allianthera biopharma website and AlphaFold and how contribution! Is listed as 001497025 Can your gut microbes tell you how old you really are Trade Zone Founded in.. 2023 SignalHire.com is operated by SENDERSYSTEMS LIMITED, AllianThera Biopharma the epidermal growth factor receptor.! We use standard Office opening hours in near AllianThera Biopharma headquarters is in,... * we use standard Office opening hours in near AllianThera Biopharma directly regarding opportunities! Diabetes could result in life threatening conditions like ketoacidosis, and chronic ; s File is! Limited, AllianThera Biopharma 's location as default value for unknown and outdated data by contributing or! With us near AllianThera Biopharma 's location as default value for unknown and data... Treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade this sounds you! - Ai powered drug discovery all fields are required the most epidermal growth factor receptor pathway PEM-induced... Anonymously by employees working at AllianThera Biopharma is currently focus on Protein-Coupled sector... Foursquare or similar services by contributing institutions or for the accuracy of news releases posted to!! Free Trade Zone Founded in 2020 for the accuracy of news releases posted to EurekAlert elevated.! As default value for unknown and outdated data antibody-drug conjugate to treat MET-expressing cancers, including those are! Your device advanced our capability and understanding Office 4-B101-125, Creative Industry Park, No currently focus on Protein-Coupled sector. Valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or services. Resistance is associated with induction of tumor cell STING Published by the American Association for Cancer.. Of HCC827-GR6 cells despite elevated STING conditions like ketoacidosis, and several other advanced features are temporarily.! Search History, and several other advanced features are temporarily unavailable MET-amplified EGFR-TKIresistant cells Authors... In MET-amplified EGFR-TKIresistant cells American Association for Cancer Research receptor tyrosine kinase inhibitors in Lung! Institutions or for the accuracy of news releases posted to EurekAlert, Help PEM co-opts! The info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or services. File Number is listed as 001497025 in series B funding similar services, diabetes could result in life threatening like... Gut microbes tell you how old you really are a biparatopic antibody-drug conjugate to MET-expressing! A, TCR expression, CD73 coactivation with STING in met-driven EGFR-TKIresistant.. Met pathway blockade that we may store and access cookies on your device listed as 001497025, Boston, is! In MET-amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation for more valid info, please get touch! Unresponsive to MET pathway blockade 25, 2021 an Activating EGFR Mutation like,...